GOSSAMER BIO, INC. (GOSS) ROE
- 2026-06-30: ROE 133.17%.
- 2026-03-31: ROE 111.71%.
- 2025-12-31: ROE 138.78%.
- 2025-09-30: ROE 189.67%.
Complete source-backed roe history.
- Available history
- 2017-12-31 to 2026-06-30
- Data captured
Historical ROE
| Date | ROE |
|---|
| 2026-06-30 | 133.17% |
|---|
| 2026-03-31 | 111.71% |
|---|
| 2025-12-31 | 138.78% |
|---|
| 2025-09-30 | 189.67% |
|---|
| 2025-06-30 | 300.92% |
|---|
| 2025-03-31 | 819.81% |
|---|
| 2024-12-31 | -191.67% |
|---|
| 2024-09-30 | -132.35% |
|---|
| 2024-06-30 | -99.17% |
|---|
| 2024-03-31 | -645.83% |
|---|
| 2023-12-31 | -286.47% |
|---|
| 2023-09-30 | -179.16% |
|---|
| 2023-06-30 | 329.28% |
|---|
| 2023-03-31 | 775.79% |
|---|
| 2022-12-31 | -1899.30% |
|---|
| 2022-09-30 | -407.98% |
|---|
| 2022-06-30 | 1401.99% |
|---|
| 2022-03-31 | -776.38% |
|---|
| 2021-12-31 | -192.65% |
|---|
| 2021-09-30 | -142.70% |
|---|
| 2021-06-30 | -108.70% |
|---|
| 2021-03-31 | -90.75% |
|---|
| 2020-12-31 | -75.89% |
|---|
| 2020-09-30 | -62.74% |
|---|
| 2020-06-30 | -53.33% |
|---|
| 2020-03-31 | -65.84% |
|---|
| 2019-12-31 | -51.15% |
|---|
| 2019-09-30 | -41.22% |
|---|
| 2019-06-30 | -37.45% |
|---|
| 2019-03-31 | -31.97% |
|---|
| 2018-12-31 | 122.40% |
|---|
Annual ROE
| Date | ROE |
|---|
| 2025-12-31 | 138.78% |
|---|
| 2024-12-31 | -191.67% |
|---|
| 2023-12-31 | -286.47% |
|---|
| 2022-12-31 | -1899.30% |
|---|
| 2021-12-31 | -192.65% |
|---|
| 2020-12-31 | -75.89% |
|---|
| 2019-12-31 | -51.15% |
|---|
| 2018-12-31 | 122.40% |
|---|
| 2017-12-31 | 98.67% |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Amneal Pharmaceuticals, Inc. (AMRX) | | $6.326B | 25.62 |
|---|